Phillip, M, Achenbach, P, Addala, A, Albanese‑O’Neill, A, Battelino, T, Bell, KJ, Besser, REJ, Bonifacio, E, Colhoun, HM, Couper, JJ, Craig, ME, Danne, T, de Beaufort, C, Dovc, K, Driscoll, KA, Dutta, S, Ebekozien, O, Larsson, HE, Feiten, DJ, Frohnert, BI, Gabbay, RA, Gallagher, MP, Greenbaum, CJ, Griffin, KJ, Hagopian, W, Haller, MJ, Hendrieckx, C, Hendriks, E, Holt, RIG, Hughes, L, Ismail, HM, Jacobsen, LM, Johnson, SB, Kolb, LE, Kordonouri, O, Lange, K, Lash, RW, Lernmark, Å, Libman, I, Lundgren, M, Maahs, DM, Marcovecchio, ML, Mathieu, C, Miller, KM, O’Donnell, HK, Oron, T, Patil, SP, Pop‑Busui, R, Rewers, MJ, Rich, SS, Schatz, DA, Schulman‑Rosenbaum, R, Simmons, KM, Sims, EK, Skyler, JS, Smith, LB, Speake, C, Steck, AK, Thomas, NPB, Tonyushkina, KN, Veijola, R, Wentworth, JM, Wherrett, DK, Wood, JR
, Ziegler, AG & DiMeglio, LA 2024, '
Correction to: Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes (Diabetologia, (2024), 67, 9, (1731-1759), 10.1007/s00125-024-06205-5)',
Diabetologia, vol. 67, no. 9, pp. 2012-2014.
https://doi.org/10.1007/s00125-024-06266-6